A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
The Role of Positive Distraction in Pediatric Design
Healthcare Waste is Fueling America's Debt
Prairie Lakes Healthcare System to Rebrand Following Sanford Health Merger
How Digital Technologies Are Reshaping Performance in Healthcare Facilities
The Role of Plumbing in Healthcare-Associated Infections